Skip to main content
Equibles

UBS Group AG

Position in IXHL — Incannex Healthcare Inc.

CIK 1610520 ZURICH, V8
Back to IXHL Full portfolio

Position in IXHL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$13,572
-$107,535 QoQ
Shares Held
3,610
-91.1% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 15 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IXHL Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names. IXHL ranks #65 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 3,643,241 $261,803,294
2 ELAN
Elanco Animal Health Inc
 9,910,822 $243,905,327
3 UTHR
UNITED THERAPEUTICS Corp
 220,616 $119,536,366
4 VTRS
Viatris Inc
 6,092,296 $96,745,659
5 LNTH
Lantheus Holdings, Inc.
 835,494 $92,689,703
6 HIMS
Hims & Hers Health, Inc.
 2,660,810 $92,250,281
7 NBIX
Neurocrine Biosciences Inc
 545,937 $92,012,220
8 TEVA
Teva Pharmaceutical Industries Ltd
 2,140,065 $72,505,400

All Filings in IXHL

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,572 3,610
2026-03-31 $121,107 40,369
2025-12-31 $51,818 144,745
2025-09-30 $78,527 169,241
2025-06-30 $15,394 71,273
2025-03-31 $4,667 6,895
2024-12-31 $19,620 9,255
2024-09-30 $5,839 2,935
2024-06-30 $17,639 6,000
2024-03-31 $10,497 2,924